To diagnose hyperglycemia of two weeks old the best investigation retrospectively is –
The core concept here is probably about the diagnostic tests for hyperglycemia, especially in neonates. For a two-week-old, acute hyperglycemia is rare but can occur due to stress, infections, or underlying conditions like diabetes. Diagnosing it retrospectively would involve tests that can show past glucose levels.
The correct answer is likely HbA1c, but wait, HbA1c reflects average blood glucose over 2-3 months. However, in a two-week-old, the red blood cell lifespan is shorter because they have a higher turnover. So HbA1c might not be reliable here. Maybe fructosamine? Fructosamine measures glycated proteins and reflects glucose levels over 2 weeks, which fits the time frame mentioned.
Let me check the options. The user didn't provide the options, but the correct answer in the previous example was fructosamine. So, the correct answer here is probably option C or D, depending on the options.
Why are the other options wrong? Let's think. Fasting blood glucose is a single point test, not retrospective. Random blood glucose also a single point. Urine glucose test is outdated and not specific. HbA1c, as mentioned, is for longer periods. So the incorrect options would be these tests.
The clinical pearl is that fructosamine is used when HbA1c isn't suitable, like in hemolytic anemia or neonates. So the key takeaway is using fructosamine for short-term monitoring in such cases.
**Core Concept**
Hyperglycemia in neonates (e.g., a two-week-old) requires retrospective investigation to assess glycemic control over time. Fructosamine, reflecting glycated serum proteins, is the preferred test for short-term glucose monitoring (2β3 weeks), while HbA1c is less reliable in neonates due to immature red blood cell turnover.
**Why the Correct Answer is Right**
Fructosamine measures glycated albumin and other serum proteins, reflecting average blood glucose levels over the preceding 2β3 weeks. This aligns with the clinical scenario of a two-week-old, where HbA1c (reflecting 2β3 months of glycemia) is inaccurate due to neonatal red blood cell turnover and hemoglobinopathy risks. Fructosamine avoids these limitations, making it ideal for retrospective hyperglycemia assessment in this age group.
**Why Each Wrong Option is Incorrect**
**Option A:** Fasting blood glucose only captures a single-point measurement, not retrospective trends.
**Option B:** Random blood glucose lacks temporal resolution and is not retrospective.
**Option D:** Urine glucose testing is outdated, insensitive, and not quantitative.
**Option C:** HbA1c is invalid in neonates due to shorter red blood cell lifespan and hemoglobin F interference.
**Clinical Pearl / High-Yield Fact**
Use **fructosamine** for glycemic monitoring in neonates or patients with